Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 2042687, 6 pages
http://dx.doi.org/10.1155/2016/2042687
Research Article

Cefazolin Irreversibly Inhibits Proliferation and Migration of Human Mesenchymal Stromal Cells

Department of Orthopaedic Surgery, Heinrich-Heine-University, 40225 Düsseldorf, Germany

Received 11 January 2016; Revised 29 February 2016; Accepted 1 March 2016

Academic Editor: Abdelwahab Omri

Copyright © 2016 Hakan Pilge et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Ponce, B. T. Raines, R. D. Reed, C. Vick, J. Richman, and M. Hawn, “Surgical site infection after arthroplasty: comparative effectiveness of prophylactic antibiotics: do surgical care improvement project guidelines need to be updated?” Journal of Bone and Joint Surgery-American Volume, vol. 96, no. 12, pp. 970–977, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. B. A. Ramo, D. W. Roberts, D. Tuason et al., “Surgical site infections after posterior spinal fusion for neuromuscular scoliosis: a thirty-year experience at a single institution,” The Journal of Bone & Joint Surgery—American Volume, vol. 96, no. 24, pp. 2038–2048, 2014. View at Publisher · View at Google Scholar
  3. G. Bicanic, K. Crnogaca, K. Barbaric, and D. Delimar, “Cefazolin should be administered maximum 30 min before incision in total knee arthroplasty when tourniquet is used,” Medical Hypotheses, vol. 82, no. 6, pp. 766–768, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. P. M. Courtneym, C. M. Melnic, Z. Zimmer, J. Anari, and G. C. Lee, “Addition of vancomycin to cefazolin prophylaxis is associated with acute kidney injury after primary joint arthroplasty,” Clinical Orthopaedics and Related Research, vol. 473, no. 7, pp. 2197–2203, 2015. View at Publisher · View at Google Scholar
  5. I. K. Yazdi, M. B. Murphy, C. Loo et al., “Cefazolin-loaded mesoporous silicon microparticles show sustained bactericidal effect against Staphylococcus aureus,” Journal of Tissue Engineering, vol. 5, 2014. View at Publisher · View at Google Scholar
  6. D. N. Williams, R. B. Gustilo, R. Beverly, and A. C. Kind, “Bone and serum concentrations of five cephalosporin drugs. Relevance to prophylaxis and treatment in orthopedic surgery,” Clinical Orthopaedics and Related Research, no. 179, pp. 253–265, 1983. View at Google Scholar
  7. M. Sampson, M. Cohen-Wolkowiez, D. Benjamin Jr., E. Capparelli, and K. Watt, “Pharmacokinetics of antimicrobials in obese children,” Generics and Biosimilars Initiative Journal, vol. 2, no. 2, pp. 76–81, 2013. View at Publisher · View at Google Scholar
  8. R. Koshida, E. Nakashima, N. Taniguchi, A. Tsuji, L. Z. Benet, and F. Ichimura, “Prediction of the distribution volumes of cefazolin and tobramycin in obese children based on physiological pharmacokinetic concepts,” Pharmaceutical Research, vol. 6, no. 6, pp. 486–491, 1989. View at Publisher · View at Google Scholar · View at Scopus
  9. G. M. Salzmann, F. D. Naal, F. von Knoch et al., “Effects of cefuroxime on human osteoblasts in vitro,” Journal of Biomedical Materials Research A, vol. 82, no. 2, pp. 462–468, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. F. D. Naal, G. M. Salzmann, F. von Knoch et al., “The effects of clindamycin on human osteoblasts in vitro,” Archives of Orthopaedic and Trauma Surgery, vol. 128, no. 3, pp. 317–323, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. S. van Kralingen, M. Taks, J. Diepstraten et al., “Pharmacokinetics and protein binding of cefazolin in morbidly obese patients,” European Journal of Clinical Pharmacology, vol. 67, no. 10, pp. 985–992, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. J. P. Southwell-Keely, R. R. Russo, L. March, R. Cumming, I. Cameron, and A. J. Brnabic, “Antibiotic prophylaxis in hip fracture surgery: a metaanalysis,” Clinical Orthopaedics and Related Research, no. 419, pp. 179–184, 2004. View at Google Scholar
  13. M. G. Dehne, J. Mühling, A. Sablotzki, H. Nopens, and G. Hempelmann, “Pharmacokinetics of antibiotic prophylaxis in major orthopedic surgery and blood-saving techniques,” Orthopedics, vol. 24, no. 7, pp. 665–669, 2001. View at Google Scholar · View at Scopus
  14. E. Paz, P. Sanz-Ruiz, J. Abenojar, J. Vaquero-Martín, F. Forriol, and J. C. Del Real, “Evaluation of elution and mechanical properties of high-dose antibiotic-loaded bone cement: comparative ‘in vitro’ study of the influence of vancomycin and cefazolin,” Journal of Arthroplasty, vol. 30, no. 8, pp. 1423–1429, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. M. L. Edin, T. Miclau, G. E. Lester, R. W. Lindsey, and L. E. Dahners, “Effect of cefazolin and vancomycin on osteoblasts in vitro,” Clinical Orthopaedics and Related Research, no. 333, pp. 245–251, 1996. View at Google Scholar · View at Scopus
  16. N. M. C. Mathijssen, G. Hannink, P. Pilot, B. W. Schreurs, R. M. Bloem, and P. Buma, “Impregnation of bone chips with alendronate and cefazolin, combined with demineralized bone matrix: a bone chamber study in goats,” BMC Musculoskeletal Disorders, vol. 13, article 44, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. Z. Zhang, X. Wang, F. Luo et al., “Effects of rifampicin on osteogenic differentiation and proliferation of human mesenchymal stem cells in the bone marrow,” Genetics and Molecular Research, vol. 13, no. 3, pp. 6398–6410, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Pulido, E. Ghanem, A. Joshi, J. J. Purtill, and J. Parvizi, “Periprosthetic joint infection: the incidence, timing, and predisposing factors,” Clinical Orthopaedics and Related Research, vol. 466, no. 7, pp. 1710–1715, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. C.-C. Chiang and F.-Y. Chiu, “Cefuroxime-impregnated cement and systemic cefazolin for 1 week in primary total knee arthroplasty: an evaluation of 2700 knees,” Journal of the Chinese Medical Association, vol. 75, no. 4, pp. 167–170, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. W. A. Jiranek, A. D. Hanssen, and A. S. Greenwald, “Antibiotic-loaded bone cement for infection prophylaxis in total joint replacement,” The Journal of Bone and Joint Surgery. American, vol. 88, no. 11, pp. 2487–2500, 2006. View at Publisher · View at Google Scholar
  21. S. W. Young, M. Zhang, J. T. Freeman, K. G. Vince, and B. Coleman, “Higher cefazolin concentrations with intraosseous regional prophylaxis in TKA,” Clinical Orthopaedics and Related Research, vol. 471, no. 1, pp. 244–249, 2013. View at Google Scholar
  22. R. Marsell and T. A. Einhorn, “The biology of fracture healing,” Injury, vol. 42, no. 6, pp. 551–555, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. F. Granero-Moltó, J. A. Weis, M. I. Miga et al., “Regenerative effects of transplanted mesenchymal stem cells in fracture healing,” Stem Cells, vol. 27, no. 8, pp. 1887–1898, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Tsuji, A. Bandyopadhyay, B. D. Harfe et al., “BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing,” Nature Genetics, vol. 38, no. 12, pp. 1424–1429, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Marsell and T. A. Einhorn, “The role of endogenous bone morphogenetic proteins in normal skeletal repair,” Injury, vol. 40, supplement 3, pp. S4–S7, 2009. View at Google Scholar · View at Scopus
  26. F. Haasters, D. Docheva, C. Gassner et al., “Mesenchymal stem cells from osteoporotic patients reveal reduced migration and invasion upon stimulation with BMP-2 or BMP-7,” Biochemical and Biophysical Research Communications, vol. 452, no. 1, pp. 118–123, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. R. S. Namba, Y. Chen, E. W. Paxton, T. Slipchenko, and D. C. Fithian, “Outcomes of routine use of antibiotic-loaded cement in primary total knee arthroplasty,” Journal of Arthroplasty, vol. 24, no. 6, pp. 44–47, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. F. D. Matl, A. Obermeier, S. Repmann, W. Friess, A. Stemberger, and K.-D. Kuehn, “New anti-infective coatings of medical implants,” Antimicrobial Agents and Chemotherapy, vol. 52, no. 6, pp. 1957–1963, 2008. View at Publisher · View at Google Scholar · View at Scopus